4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-042457
Director acquired 1,424 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2022-07-15 | Option exercise | +535 | $2.11 | $1,129 | 90,097 | D |
| Anderson Kenneth Carl Director | 2022-07-15 | Option exercise | +889 | $4.98 | $4,427 | 90,986 | D |
| Derivatives | |||||||
| Anderson Kenneth Carl Director | 2022-07-15 | Option exercise · Stock Option (Right to Buy) | −535 | 1,602 | D | ||
| Anderson Kenneth Carl Director | 2022-07-15 | Option exercise · Stock Option (Right to Buy) | −889 | 1,779 | D | ||
Loading xslF345X03/doc4.xml…